Research Paper Volume 12, Issue 5 pp 4603—4616
The prognostic value of tumor mutational burden and immune cell infiltration in esophageal cancer patients with or without radiotherapy
Figure 4. The subgroup analysis in patients receiving radiotherapy or not. (A) Survival analysis to explore the OS of EC patients between the TMB-H and TMB-L group. (B) OS between the TMB-H and TMB-L group of patients receiving radiotherapy. (C) OS of the TMB-H group decreased significantly in EC patients with radiotherapy. (D–G) The different gene expression between the TMB-H and TMB-L groups in EC patients receiving radiotherapy or not.